1,4-Dioxane → n-Acetyl-6-isopropyl-1-oxo-1,2-dihydrobenzo[c]-1,6-naphthyridine-9-carbohydrazide
Reaction equation
Br[C:2]1[CH:19]=[CH:18][C:5]2[C:6]([CH:15]([CH3:17])[CH3:16])=[N:7][C:8]3[CH:9]=[CH:10][NH:11][C:12](=[O:14])[C:13]=3[C:4]=2[CH:3]=1.C([PH+](C(C)(C)C)C(C)(C)C)(C)(C)C.[H+].[B-](F)(F)(F)F.[O:39]1[CH2:44][CH2:43]OCC1.C([N:48](CC)C(C)C)(C)C.C[C:55]([N:57](C)C)=[O:56]>[C-]#[O+].[C-]#[O+].[C-]#[O+].[C-]#[O+].[C-]#[O+].[C-]#[O+].[Mo].CC1C(P(C2C([CH2-])=CC=CC=2)C2C(C)=CC=CC=2)=CC=CC=1.CC1C(P(C2C([CH2-])=CC=CC=2)C2C(C)=CC=CC=2)=CC=CC=1.CC(O)=O.CC(O)=O.[Pd].[Pd]>[C:44]([N:57]([C:55]([C:2]1[CH:19]=[CH:18][C:5]2[C:6]([CH:15]([CH3:17])[CH3:16])=[N:7][C:8]3[CH:9]=[CH:10][NH:11][C:12](=[O:14])[C:13]=3[C:4]=2[CH:3]=1)=[O:56])[NH2:48])(=[O:39])[CH3:43]Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 100 °C
Procedure
9-bromo-6-isopropylbenzo[c]-1,6-naphthyridin-1(2H)-one (100 mg, 0.32 mmol), acetichydrazide (47 mg, 0.63 mmol), molybdenum hexacarbonyl (83 mg, 0.32 mmol), trans-di-mu-acetatobis[2-(di-o-tolylphosphino)benzyl]dipalladium(II) (15 mg, 0.016 mmol), and tri-(t-butyl)phosphonium HBF4 salt (9.2 mg, 0.032 mmol) were combined in a vial, followed by dioxane (2.0 ml), DMA (1.0 ml) and N,N-diisopropylethylamine (0.22 ml, 1.3 mmol). The resulting suspension was purged with argon (subsurface bubbling) for 10 min, and then stirred at 100° C. in a sealed vial for 3 hours. The reaction mixture was cooled to room temperature, diluted with EtOAc (3 mL), and filtered to afford N-acetyl-6-isopropyl-1-oxo-1,2-dihydrobenzo[c]-1,6-naphthyridine-9-carbohydrazide. 1H NMR (500 MHz, DMSO-D6) δ 11.88 (d, 1H), 10.53 (s, 1H), 10.47 (d, 1H), 9.97 (s, 1H), 8.56 (d, 1H), 8.06 (dd, 1H), 7.57 (t, 1H), 6.79 (d, 1H), 4.12 (septet, 1H), 1.94 (s, 3H), 1.38 (d, 6H). LRMS (ESI) calc'd for (C18H18N4O3) [M+H]+, 339.1; found 339.1.
Workup
- customThe resulting suspension was purged with argon (subsurface bubbling) for 10 min
- temperatureThe reaction mixture was cooled to room temperature
- additiondiluted with EtOAc (3 mL)
- filtrationfiltered
Sources & evidence
- ORD record
- ord-245186ffe5bd40a083292f3e08767dcf
- Source dataset
- uspto-grants-2012_12
- Patent number
- US08329722B2
Reaction notes
Loading…